Remed Co.Ltd (302550) — Cash Flow Reinvestment Rate

Latest as of March 2026: 10.00x

Remed Co.Ltd (302550) has a Cash Flow Reinvestment Rate of 10.00x as of March 2026, reinvesting ₩2.39 Billion (capex ₩88.33 Million plus investments ₩2.30 Billion) from operating cash flow of ₩238.69 Million. See Remed Co.Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

10.00x
(Capex + Investments) / Operating CF

Total Reinvested

₩2.39 Billion
Capex + Investments

Operating Cash Flow

₩238.69 Million
KRW

Capital Expenditures

₩88.33 Million
KRW

Remed Co.Ltd Cash Flow Reinvestment Rate (2017–2025)

Historical reinvestment intensity for Remed Co.Ltd across 7 annual periods. For the full cash flow conversion analysis, see Remed Co.Ltd operating cash flow efficiency.

Annual Cash Flow Reinvestment Rate for Remed Co.Ltd (2017–2025)

Year-by-year capital reinvestment analysis for Remed Co.Ltd. See Remed Co.Ltd (302550) flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2025 2.67x ₩6.41 Billion ₩2.40 Billion ₩868.76 Million ▼ -53.0%
2024 5.69x ₩7.08 Billion ₩1.24 Billion ₩608.80 Million ▼ -9.3%
2023 6.27x ₩21.95 Billion ₩3.50 Billion ₩893.97 Million ▲ +531.3%
2022 0.99x ₩5.18 Billion ₩5.21 Billion ₩4.77 Billion ▼ -92.6%
2020 13.44x ₩34.81 Billion ₩2.59 Billion ₩679.62 Million ▲ +740.3%
2019 1.60x ₩5.15 Billion ₩3.22 Billion ₩2.01 Billion ▼ -86.1%
2017 11.52x ₩768.89 Million ₩66.75 Million ₩768.89 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow